Tag: Remdesivir

New York: New data revealed by Gilead Sciences has shown that its antiviral drug remdesivir reduces death risk of severe Covid-19 patients by as much as 62 per cent when compared with standard care alone. This is an important finding that requires confirmation in prospective clinical trials, Gilead said on Friday about the results presented […]

Bengaluru: Global pharmaceutical company Mylan on Monday announced the commercial launch of the generic version of Gilead Sciences’s antiviral drug remdesivir under the brand name ‘DESREM’ in India to address urgent needs amid Covid-19. Available at a price of Rs 4,800 per 100mg vial, the drug costs more than 80 per cent less than the […]

New Delhi: Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory […]

Bhubaneswar: The Directorate of Drugs Control, Odisha today allowed the retail sale of Covid-19 drugs Remdesivir and Fevipiravir as per the directives of the Drugs Controller General India (DCGI). However, both the COVID drugs will be sold on certain conditions. DCGI has directed that the Fevipiravir tablets and Remdesivir injectable formulation will be sold under […]

New Delhi: The Supreme Court on Wednesday said the Centre has framed rules on drugs clinical trial and there is also an approval on the use of Remdesivir and Favipiravir as medicines to treat Covid-19. A bench headed by Chief Justice S A Bobde and comprising Justices A S Bopanna and V Ramasubramanian, citing the […]

New Delhi: The government has been alerted about the massive black marketing of Covid drug Remdesivir, which according to some evidence is selling for as high as Rs 50,000, over…

Bhubaneswar: Amid the confusion over the use of plasma therapy and Remdesivir for treating COVID-19 patients, Odisha Health Secretary Pradipta Mohapatra today clarified that the State is yet to receive any official statement from ICMR related to the ineffectiveness of the therapy or the use of the anti-viral drug in treating the infected patients. The […]

Washington: US regulators have given full approval for the antiviral drug remdesivir to treat the Covid-19 patients in hospitals. The US Food and Drug Administration (FDA) said Veklury, the drug’s brand name, cut the recovery time on average by five days during clinical trials. “Veklury is the first treatment for COVID-19 to receive FDA approval,” […]

Geneva: The World Health Organization (WHO) on Friday warned that the antiviral drug remdesivir should not be used to treat Covid-19 patients no matter how ill they are as there is no evidence it works. “The panel found a lack of evidence that remdesivir improved outcomes that matter to patients such as reduced mortality, need […]